Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2003
02/26/2003EP1284728A1 Pharmaceuticals for treating obesity
02/26/2003EP1284720A2 Method of treating hepatitis delta viral infection
02/26/2003EP1212453A4 Method to identify gene function using small molecule probes
02/26/2003EP1036192B1 Fluorescence-based high throughput screening assays for protein kinases and phosphatases
02/26/2003EP1019423B1 Method for producing a pentopyranosyl nucleoside
02/26/2003EP0990149A4 Nucleic acid sensor
02/26/2003EP0944734B1 Bacillus strain and antibiotic screening method
02/26/2003EP0920626B1 Method for isolating a target biological material, capture phase, detecting phase and reagent containing them
02/26/2003EP0882233B1 Method and device for treatment by complexing of a liquid medium
02/26/2003EP0877941B1 Method for bulk enrichment of a population or subpopulation of cells
02/26/2003EP0759943B1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
02/26/2003CN2537978Y Optical fibre pre-buried concrete stick sensor
02/26/2003CN1399723A Spectrophotometric measurement in color-based biochemical and immunologigal assays
02/26/2003CN1399722A Compositions and Methods for detecting treponema pallidum
02/26/2003CN1399719A Method and device for determining quality of fluids
02/26/2003CN1399717A Method and device for characterizing culture liquid
02/26/2003CN1399716A Direct aspiration-reaction and injection device and methods of use
02/26/2003CN1399680A 上皮细胞生长抑制剂 Epithelial cell growth inhibitor
02/26/2003CN1399678A Human Enzymes of metalloprotease family
02/26/2003CN1399645A Human monolonal antibodies to HER2/NEU
02/26/2003CN1399644A Novel human G-Protein coupled receptor
02/26/2003CN1399563A Method for early prediction of onset of invasive cancer
02/26/2003CN1399562A Method of treating lupus based on antibody affinity and screening methods and compositions for use thereof
02/26/2003CN1399133A Human vascular IBP-like growth factor
02/26/2003CN1399132A Polynary immunoassay board
02/26/2003CN1399131A Woundless blood cell parameter measuring method
02/26/2003CN1399130A Device and method for measuring sample resistivity
02/26/2003CN1102241C Composition for separating serum or plasma
02/26/2003CN1102238C Method for stable isotope measure using spectroscope
02/26/2003CA2420656A1 Antisense oligonucleotides against vanilloid receptor 1
02/25/2003US6526369 Apparatus and process for a cross-direction profile of a material web
02/25/2003US6526363 System and method for calibration and verification of a sample analysis instrument
02/25/2003US6526154 Method and apparatus for determining the portion of wood material present in a stream of bark
02/25/2003US6526119 Method and arrangement for determining the moisture content of wood chips
02/25/2003US6525549 Method for determining the concentration of a substance in a liquid by measuring electrical current in a test strip
02/25/2003US6525325 System for quantifying the hydrocarbon content of aqueous media
02/25/2003US6525187 Polynucleotide encoding autoantigens associated with endometriosis
02/25/2003US6525186 Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful of serologic diagnosis of canine leishmaniosis and protein obtained
02/25/2003US6525180 Antibodies to mammalian T cell surface antigen
02/25/2003US6525179 Methods and compositions for impairing multiplication of HIV-1
02/25/2003US6525178 PGC-1, a novel brown fat PPARgamma coactivator
02/25/2003US6525174 Precerebellin-like protein
02/25/2003US6525017 Using glutathiane to protect neurons from injury
02/25/2003US6524866 Capillary electrophoretic method to detect target-binding ligands and to determine their relative affinities
02/25/2003US6524865 Electrochemiluminescent enzyme immunoassay
02/25/2003US6524864 Test strip for simultaneous detection of a plurality of analytes
02/25/2003US6524862 Assaying hemoglobin or a hemoglobin analogue by reacting the sample with a lipoprotein that selectively forms a complex with the hemoglobin; kits
02/25/2003US6524861 Blood coagulation analyzer
02/25/2003US6524858 Single channel, single dilution detection method for the identification and quantification of blood cells and platelets in a whole blood sample using an automated hematology analyzer
02/25/2003US6524829 Method for DNA- or RNA-sequencing
02/25/2003US6524819 And their use in the screening for compounds of use in characterization, diagnosis, and treatment of conditions such as Alzheimer's disease, Down syndrome and other forms of dementia
02/25/2003US6524817 DNA encoding a receptor subunit for oncostatin M
02/25/2003US6524813 Novel polynucleotides and polypeptides of the spo0J family derived from Staphylococcus
02/25/2003US6524810 Making a non-viable preparation of cells by the addition of bleomycin/phleomycin anitibiotics which retains signal-generating metabolic activity such as bioluminescence
02/25/2003US6524809 Analytical method using multiple virus labelling
02/25/2003US6524808 Combining analyte with ligand-inhibitor conjugate comprising ligand of analyte and an uncompetitive inhibitor of IMPDH, a receptor specific for said analyte, IMP, NAD and IMPDH; NADH production indicates presence or amount of analyte
02/25/2003US6524806 Methods of screening for ligands of human hemetopoietin receptor HU-B1.219
02/25/2003US6524805 Cell expressing said receptors contacted with test compound; if induced response is inhibited by tamoxifen, but not by internal estrogen receptor antagonist then test compound is an agonist
02/25/2003US6524804 Process for determining antibiotics containing a β-lactam ring in a biological fluid
02/25/2003US6524802 Methods of detecting growth differentiation factor-14
02/25/2003US6524799 DNA encoding sparc-related proteins
02/25/2003US6524798 High efficiency methods for combined immunocytochemistry and in-situ hybridization
02/25/2003US6524797 Contacting a cell indicative of said pathological condition from a diseased human individual and a control cell from normal genetically related human with a plurality of drugs
02/25/2003US6524795 Diagnostics for cardiovascular disorders
02/25/2003US6524794 DNA from two related individuals is digested forming two digested samples; one sample is methylated; two samples are allowed to hybridize; specifically digested leaving perfectly-matched heterohybrid DNA fragments
02/25/2003US6524793 Enables the simultaneous, and automated, detection and interpretation of multiple biomolecules or DNA sequences in real-time while also reducing the cost of performing diagnostic and genetic assays
02/25/2003US6524791 Analyzing a repeat region of a spinocerebellar ataxia type 8 coding sequence wherein individuals who are at-risk have at least about 80 CTG repeats in the repeat region or at least about 92 combined CTA and CTG repeats in the repeat region
02/25/2003US6524790 Apparatus and methods for correcting for variable velocity in microfluidic systems
02/25/2003US6524788 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
02/25/2003US6524786 Scintillation proximity test
02/25/2003US6524582 Methods and compositions for impairing multiplication of HIV-1
02/25/2003US6524530 Sample collecting member and wiping inspection instrument
02/25/2003US6523426 Water quality measuring apparatus with a sensing wafer clamped between two o-rings
02/25/2003US6523416 Method for setting shape and working stress, and working environment of steel member
02/25/2003US6523395 Method and measuring apparatus for measuring freeness
02/25/2003CA2282658C A system for cell-based screening
02/25/2003CA2231192C Pharmaceutical combination preparations containing erythropoietin and iron preparations
02/25/2003CA2093415C Test method and reagent kit therefor
02/25/2003CA2048910C Antimicrobial peptides active against plant pathogens, their method of use and various screening methods pertaining thereto
02/25/2003CA2019048C Cloth enzyme immunoassay
02/25/2003CA1341422C Retinoic acid receptor composition and method
02/24/2003CA2426408A1 Method of protecting personal information
02/23/2003CA2356003A1 Zero length cross-linking of proteins
02/21/2003WO2002016610A1 Novel protease gene
02/21/2003CA2420275A1 Novel protease gene
02/20/2003WO2003015009A1 Method and device for identifying a marker using a detector substance
02/20/2003WO2003014960A2 Method of identifying a consensus sequence for intracellular antibodies
02/20/2003WO2003014879A2 System and method for identifying a genetic risk factor for a disease or pathology
02/20/2003WO2003014746A2 Method for identifying proteins with n-terminal n-myristoylation
02/20/2003WO2003014745A2 Method for identifying anti-inflammatory drugs
02/20/2003WO2003014744A2 Method and diagnostic kit for diagnosing helicobacter pylori
02/20/2003WO2003014743A2 Use of dendrimers and poly-branched molecules to enhance signal in fluorescent assay systems
02/20/2003WO2003014742A2 Identification of human auto-antibodies
02/20/2003WO2003014741A1 Biosensor and method for analyzing blood components using it
02/20/2003WO2003014740A1 Biosensors and measurement method
02/20/2003WO2003014739A1 Method and device for integrated biomolecular analyses
02/20/2003WO2003014738A2 Substance support provided with a marking
02/20/2003WO2003014736A1 Biological molecules comprising glycosaminoglycans
02/20/2003WO2003014734A1 Method of detecting interaction between substance and protein, method of screening protein interacting with substance, and method of forming complex of substance and protein interacting with the substance
02/20/2003WO2003014733A2 Methods and markers for identifying activated synapses